Discover 525 paid clinical trials in Hershey, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 525
Observational Study Protocol: LIVER-R
for
Hepatobiliary Cancers
Location: Lancaster PA, Bethlehem PA, Philadelphia PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06252753
Recruiting
Left vs Left Randomized Clinical Trial
for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Lancaster PA, Allentown PA, Philadelphia PA,
Sponsor: Baylor College of Medicine
Sex: All
Age: 18+
Code: NCT05650658
Recruiting
Foundational Programs to Combat Clinician Stress
for
Burnout, Professional, Stress, Psychological,
Location: Lancaster PA, Philadelphia PA, Plainsboro NJ, Boston MA
Sponsor: Lancaster General Hospital
Sex: All
Age: 25 - 70
Code: NCT07220421
Recruiting
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
Location: Lancaster PA, York PA, Sayre PA, Binghamton NY,
Sponsor: Paradigm Health
Sex: All
Age: 18+
Code: NCT06605404
Recruiting
Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair
for
Heart Failure
Location: Lancaster PA, Philadelphia PA, Newark NJ, Cleveland OH,
Sponsor: Acorn Cardiovascular, Inc.
Sex: All
Age: 18 - 70+
Code: NCT00630266
Phase2, Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Lancaster PA, York PA, Winchester VA, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase3, Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Lancaster PA, Baltimore MD, Columbia MD,
Location: Lancaster PA, West Chester PA, Philadelphia PA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 18+
Code: NCT06772675
Recruiting
The Radiation Oncology Registry and Biosample Repository
for
Neoplasia
Location: Lancaster PA, Philadelphia PA, Voorhees Township NJ
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT01577251
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Lancaster PA, York PA, Towson MD, Baltimore MD,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Pan Tumor Rollover Study
for
Cancer
Location: Lancaster PA, Mineola NY, Toronto, Boston MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT03899155
Phase2, Recruiting
Impact of Complimentary and Alternative Practices on Patient Wellbeing During Rehabilitation
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: York PA, Baltimore MD, Newark NJ, Morgantown WV,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase2, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: York PA, Newark DE, Columbia MD, White Plains NY,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase3, Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Location: York PA, Philadelphia PA, East Brunswick NJ,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 18+
Code: NCT05059444
Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: York PA, Frederick MD, Ithaca NY, East Syracuse NY,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: York PA, Broomall PA, Fairfax VA, Hackensack NJ,